Gilead Sciences Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, and welcome to the 40th Annual JPMorgan Healthcare Conference. My name is Cory Kasimov, I'm the senior large-cap biotech analyst, and it's my pleasure to introduce Gilead and Chairman and CEO, Daniel O'Day. (Operator Instructions)
So with that, Dan, thank you very much for being here. Always great speaking with you. Now let me hand things over to you for your presentation.
' -
Great. Well, thanks, Cory. I'm really pleased to be here today and representing the colleagues at Gilead. And I want to thank you, Cory, and everybody for the quick pivot to the virtual setting. And I know that's -- that was a heavy lift.
I want to start out by saying we are really looking forward to what promises to be another strong year for Gilead and frankly, a strong decade for Gilead. We're coming off a year of very positive momentum where we increased our full year total
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
